This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
NVIDIA's (NVDA) Q4 Earnings to be Hurt by Weak Chip Demand
by Zacks Equity Research
NVIDIA's (NVDA) overall financial performance in the fourth quarter of fiscal 2023 is likely to have been hurt by the weakening demand for chips used in the gaming end market.
Twilio (TWLO) Jumps 12% on Q4 Earnings Beat, Strong Guidance
by Zacks Equity Research
Twilio's (TWLO) Q4 performance reflects the benefits of the constant expansion of its international business and the continuous acceleration of digital transformation projects across several industries.
Sabre (SABR) Plunges 19% on Wider-Than-Expected Q4 Loss
by Zacks Equity Research
Sabre's (SABR) lower-than-expected Q4 top-line performance raises concerns for the slow post-pandemic recovery of the travel technology company.
Sabre (SABR) Renews Multi-Year Deal With JetBlue Airways
by Zacks Equity Research
The latest renewed multi-year agreement with JetBlue Airways depicts the growing trust in Sabre's (SABR) PSS and GDS solutions by leading air carriers.
Clarivate PLC (CLVT) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Clarivate PLC (CLVT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
CyberArk (CYBR) Q4 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
CyberArk's (CYBR) fourth-quarter 2022 results reflect the strong demand for the company's SaaS solutions and on-premise subscription offerings.
New Strong Buy Stocks for February 10th
by Zacks Equity Research
SNEX, DTEGY, CLVT, HAE and ARCC have been added to the Zacks Rank #1 (Strong Buy) List on February 10, 2022.
Sangoma Technologies Corporation (SANG) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Sangoma Technologies Corporation (SANG) delivered earnings and revenue surprises of 0% and 7.58%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Paycom (PAYC) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Paycom's (PAYC) Q4 results reflect the benefits of strong demand, new business wins and the adoption of recent new product offerings.
NCR Corporation (NCR) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
NCR Corporation's (NCR) Q4 results reflect strong execution, solid growth across business segments, increased pricing and cost-saving actions.
Fortinet (FTNT) Soars 13% on Q4 Earnings Beat, Strong Guidance
by Zacks Equity Research
The strong demand for Core and Enhanced Platform Technologies aids Fortinet's (FTNT) Q4 top line, while an improved supply chain, positive pricing actions and discounting policies in the Product segment drive earnings higher.
Is Clarivate (CLVT) Outperforming Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Here is how Clarivate PLC (CLVT) and Lyft (LYFT) have performed compared to their sector so far this year.
Gen Digital (GEN) Tops on Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Gen Digital's (GEN) Q3 results reflect strong customer growth and the benefits of the global business expansion and the Avast acquisition, leading to year-over-year growth in revenues and bookings.
Paylocity (PCTY) Soars 4% on Q2 Earnings Beat, Guidance Raise
by Zacks Equity Research
Better sales execution and sustained investments in technological upgrades and product innovation drive Paylocity's (PCTY) Q2 earnings and revenues higher.
Time to Buy these Top-Rated Growth Stocks at a Discount?
by Shaun Pruitt
These three stocks have seen stellar EPS growth over the last five years and their attractive valuations make them appear to have more short-term upside in addition to being solid long-term investments.
Zacks.com featured highlights include Clarivate, Expedia Group and Haemonetics
by Zacks Equity Research
Clarivate, Expedia Group and Haemonetics are part of the Zacks Screen of the Week article.
Time To Pick These 3 Top Relative Price Strength Stocks
by Nilanjan Choudhury
Clarivate Plc (CLVT), Expedia Group (EXPE) and Haemonetics Corporation (HAE) are three stocks with explosive relative price strength.
The Zacks Analyst Blog Highlights AMN Healthcare Services, Clarivate, Core & Main, CRH and Deere & Co.
by Zacks Equity Research
AMN Healthcare Services, Clarivate, Core & Main, CRH and Deere & Co. are part of the Zacks top analyst blog.
Wall Street Books Best Week Since November: 5 Growth Picks
by Tirthankar Chakraborty
The stock market gains momentum as consumer sentiment improves on fading inflation. Thus, invest in growth players like AMN Healthcare Services (AMN), Clarivate (CLVT), Core & Main (CNM), CRH & Deere (DE) for solid returns.
How Much Upside is Left in Clarivate PLC (CLVT)? Wall Street Analysts Think 39.2%
by Zacks Equity Research
The mean of analysts' price targets for Clarivate PLC (CLVT) points to a 39.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Is the Options Market Predicting a Spike in Clarivate (CLVT) Stock?
by Zacks Equity Research
Investors need to pay close attention to Clarivate (CLVT) stock based on the movements in the options market lately.
Clarivate PLC (CLVT) Q3 Earnings Beat Estimates
by Zacks Equity Research
Clarivate PLC (CLVT) delivered earnings and revenue surprises of 17.65% and 1.20%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Vishay Intertechnology (VSH) Q3 Earnings Beat Estimates
by Zacks Equity Research
Vishay (VSH) delivered earnings and revenue surprises of 9.41% and 0.04%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Clarivate PLC (CLVT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Clarivate PLC (CLVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is the Options Market Predicting a Spike in Clarivate (CLVT) Stock?
by Zacks Equity Research
Investors need to pay close attention to Clarivate (CLVT) stock based on the movements in the options market lately.